Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Celltrion Sees Little Threat From ‘Overheated’ Biosimilar Competition
Presenting Q2 Results, Korean Giant Questions Ability Of Smaller Players To Survive
15 Aug 2024
•
By
Dave Wallace
Celltrion believes smaller biosimilars players will struggle to compete with larger outfits • Source: Shutterstock
More from Biosimilars
More from Products